IRD offering history
Every offering-related filing in Opus Genetics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,003 filings back to May 17, 2005.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 7, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 17, 2026 | 424B2 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
| Jun 15, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 5, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 22, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 21, 2026 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Apr 7, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 13, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 19, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 6, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 6, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Aug 25, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 26, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 10, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 8, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Apr 4, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 24, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 24, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 21, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Mar 20, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 20, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 18, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 13, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 22, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 16, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 23, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 10, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 14, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 7, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 11, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 17, 2021 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Feb 12, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 11, 2021 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Feb 4, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 25, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 2, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 2, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 11, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 2, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 3, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
IRD offering FAQ
When did IRD last execute an offering?
Per SEC filings, Opus Genetics, Inc.'s most recent priced offering document is a 424B2 filed 2026-06-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did IRD last announce or register an offering?
The most recent registration is a S-3 filed 2026-08-07. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.